₹2,238.80
+54.10 (+2.48%)
As of 18 Sept 2026, Hester Biosciences Ltd share price is ₹2,238.80. The stock opened at ₹2,238.80 and had closed at ₹2,184.70 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,250.95 and a high of ₹2,669.00. In terms of performance, Hester Biosciences Ltd share price has increased by 55.50% over the past six months and has increased by 8.81% over the last year.
HESTERBIO Stock Price Chart
Hester Biosciences Ltd Overview
Market cap₹1,858 Crs
Volume312
Prev. Close₹2,184.70
Year range₹1,250.95 - ₹2,669.00
ISININE782E01017
About HESTERBIO
Hester Biosciences is principally engaged in manufacturing of veterinary vaccines and trading of veterinary health products.
Hester Biosciences Ltd Historical Performance
1 Month Return-9.66%
6 Month Return50.80%
3 Year Return26.71%
3 Month Return6.75%
1 Year Return6.13%
5 Year Return-12.69%
Hester Biosciences Ltd Fundamentals
ROCE(TTM)13.78%
P/E Ratio (TTM)31.52
P/B Ratio4.82
Debt to Equity0.19
ROE12.17%
EPS (TTM)63.10
Dividend Yield0.50%
Book Value452.79
Profit Margin17.82%
Operating Margin23.70%
Hester Biosciences Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 299.78 | 291.23 | 289.42 | 259.32 | 224.01 |
| EBITDA | 87.10 | 55.71 | 51.60 | 60.21 | 65.23 |
| Net Profit | 52.10 | 31.84 | 27.16 | 32.34 | 39.52 |
| EPS | 61.24 | 37.43 | 31.93 | 38.02 | 46.45 |
Hester Biosciences Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 2,145.73 |
| Resistance 1 (R1) | 2,218.83 |
| Pivot Point | 2,179.87 |
Hester Biosciences Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 14-Jul-2026 | 15-May-2026 | 14-Jul-2026 | Final | ₹11.00 |
| 06-Aug-2025 | 09-May-2025 | 06-Aug-2025 | Final | ₹7.00 |
| 22-Aug-2024 | 10-May-2024 | 23-Aug-2024 | Final | ₹6.00 |
| 13-Sep-2023 | 17-May-2023 | 14-Sep-2023 | Final | ₹8.00 |
| 11-Aug-2022 | 20-May-2022 | 12-Aug-2022 | Final | ₹10.00 |
HESTERBIO Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Bhupendra V Gandhi | Chairman |
| Rajiv D Gandhi | Managing Director & Chief Executive Officer |
| PRIYA RAJIV GANDHI | Executive Directorector |
Hester Biosciences Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Hester Biosciences Ltd today is ₹2,238.80 on NSE and ₹2,238.80 on BSE.
- The 52-week high of Hester Biosciences Ltd is ₹2,669.00, while the 52-week low is ₹1,250.95.
- The current market capitalisation of Hester Biosciences Ltd is approximately ₹1,858 crore.
- The P/E (Price-to-Earnings) ratio of Hester Biosciences Ltd is 30.07. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Hester Biosciences Ltd is 3.78. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Hester Biosciences Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for HESTERBIO on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Hester Biosciences Ltd has delivered a return of approximately 26.71%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Hester Biosciences Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 53.73% promoters, 0.31% FIIs, 0.00% DIIs, and 33.00% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
